Sodium Glucose Cotransporter 2 Inhibitors and Amputation Risk: Achilles' Heel or Opportunity for Discovery?

Circulation. 2018 Apr 3;137(14):1460-1462. doi: 10.1161/CIRCULATIONAHA.118.032745.
No abstract available

Keywords: Editorials; SGLT2 inhibitor; amputation; critical limb ischemia; diabetes.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amputation, Surgical
  • Canagliflozin
  • Cohort Studies
  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Canagliflozin